title: [Efficacy of the conservative treatment of patients with inoperable esophageal cancer].
abstract: The results of gamma-beam therapy of esophageal cancer leave much to be desired. However betatron therapy improves them. To compare the results of esophageal cancer therapy 4 therapeutic modalities were employed: the 1st group--chemoradiotherapy (methotrexate at a weekly dose of 45 mg), the 2nd group--chemoradiotherapy (methotrexate at a dose of 10 mg alternating with prospidin at a dose of 200 mg), the 3rd group--radiotherapy (inhibitory radiation), the 4th group--radiotherapy (gamma-beam therapy). Higher efficacy of chemoradiotherapy as compared to radiotherapy only was established.
authors.forename: N A
authors.initials: NA
authors.lastname: Azhigaliev
authors.forename: S S
authors.initials: SS
authors.lastname: Sadykov
authors.forename: S K
authors.initials: SK
authors.lastname: Kusherbaev
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011379:Prognosis; D011447:Prospidium / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011447:Prospidium; D008727:Methotrexate
vernacular_title: Effektivnost' konservativnogo lecheniia neoperabel'nykh bol'nykh rakom pishchevoda.